MTOR and prostate cancer: Androgen receptor (AR), MAPK, and WNT signaling cascades are among the major interplaying oncogenic signaling cascades that may activate the PI3K-AKT-mTOR pathway and thus promote prostate cancer growth and drug resistance [177].